PDL Biopharma just recently took out a debt facility due by next year and this immediately dipped the stock until Friday April 10 when it popped up far enough to cross the 20 and 50 day moving averages in a single session on higher than average volume.
This tripped the MACD to cross upward and the RSI to cross the 50 line.
The weekly candles show a distinct hammer candle and this may bode well for the week(s) to come.
The weekly charts seem to have the 13 and 20-week moving averages as lines of resistance. If these are broken in the coming week, then this may very well signal a reversal of the downward trend for this stock. Friday's move was so strong that the A/D line on the weekly chart was also tipped upward after the previous 4 days were all in distribution.
SO, the trade plan for Monday is to try to acquire 1,000 shares of PDLI at $7.10 on a dip from the high, and then start looking for the exit around $7.80. I would set a $0.10 moving stop once it passes $7.50 so that it would not require constant monitoring.
PGN
I'm holding a little PGN into next week after it broke above its 20-day moving average on Thursday and then held support during the Friday sell-off from the traders. That seems to indicate investor support and during after hours trading on Friday someone bought 56,600 shares on the ask price in 4 transactions. This was either a short-seller getting out of the way or someone willing to make an $87,730 bet with premium transaction fees for after-hours trading. If someone has got money like that to put into this with those premium fees, I bet he knows something.
I'm not planning on necessarily keeping this one for the whole week, but we'll see how the performance pans out. There's a lot of room for this one to run if the trend actually reverses.












